Home
|
About us
|
Editorial board
|
Search
|
Ahead of print
|
Current issue
|
Archives
|
Submit article
|
Instructions
|
Subscribe
|
Contacts
|
Advertise
|
Login
Search Article
Advanced search
Users Online: 949
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Table of Contents
July-August 2016
Volume 20 | Issue 4
Page Nos. 415-582
Online since Friday, June 3, 2016
Accessed 128,851 times.
PDF access policy
Journal allows immediate open access to content in HTML + PDF
EPub access policy
Journal allows immediate open access to content EPub format
View issue as eBook
Author Institution Mapping
Issue citations
Issue statistics
RSS
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
EDITORIALS
Glycemic control in Intensive Care Unit
p. 415
Mala Dharmalingam
DOI
:10.4103/2230-8210.183459
PMID
:27366704
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Triglyceride and cardiovascular risk: A critical appraisal
p. 418
Awadhesh Kumar Singh, Ritu Singh
DOI
:10.4103/2230-8210.183460
PMID
:27366705
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (18) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Metabolic state of the nation: Results of the national family health survey-4
p. 429
Arun Kumar, Sanjay Kalra, AG Unnikrishnan
DOI
:10.4103/2230-8210.183453
PMID
:27366706
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (3) ]
[PubMed]
[Sword Plugin for Repository]
Beta
ORIGINAL ARTICLES
Novel multiple endocrine neoplasia type 1 variations in patients with sporadic primary hyperparathyroidism
p. 432
S Birla, E Malik, VP Jyotsna, A Sharma
DOI
:10.4103/2230-8210.183467
PMID
:27366707
Background and Objectives:
Primary hyperparathyroidism (PHPT) can occur either as a sporadic case or in association with syndromes such as multiple endocrine neoplasia. Multiple endocrine neoplasia type 1 (
MEN1
) is a rare autosomal-dominant disease resulting from mutations in
MEN1
gene encoding a 621 amino acid long tumor suppressor protein “menin.” We report here the results of
MEN1
screening in 31 patients diagnosed with sporadic PHPT.
Materials and Methods:
Diagnosis of sporadic PHPT was made when blood urea and serum creatinine were normal, serum parathyroid hormone was high, and parathyroid enlargement could be localized on ultrasound and/or parathyroid scan. A total of 31 patients and 50 healthy volunteers were recruited for molecular analysis after taking informed consent.
Results:
Major symptoms at presentation were bone pain, fatigue, muscle weakness, and renal stones. Molecular genetic analysis revealed the presence of two novel intronic variations, c. 913-79T>A and c. 784-129T>A which by human splicing finder are predicted to cause potential alteration of splicing by either activating an intronic cryptic acceptor site or converting a conserved exonic splicing silencer sequence to an exonic splicing enhancer site. Apart from these, two reported polymorphisms rs144677807 and rs669976 were seen only in patients and none of the controls. Other reported polymorphisms rs2071313 and rs654440 were identified both in controls and patients.
Conclusions:
This is the first study of
MEN1
gene screening in sporadic PHPT in India reporting on the clinical and genetic findings, wherein two novel intronic variations c. 913-79T>A and c. 784-129T>A were identified showing their possible role in disease causation.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Prevalence of colonic polyp and its predictors in patients with acromegaly
p. 437
Purnima Agarwal, Praveer Rai, Manoj Jain, Shambhavi Mishra, Uttam Singh, Sushil Kumar Gupta
DOI
:10.4103/2230-8210.183455
PMID
:27366708
Background:
There are conflicting data regarding the prevalence of colorectal polyp in patients with acromegaly.
Subjects and Methods:
Consecutive forty-seven acromegalic patients (21 men, 26 women), with a mean age of (40 ± 12 years) attending endocrinology outpatient department underwent full colonoscopy. All the patients underwent clinical and biochemical evaluation (glucose suppressed growth hormone (GH), Insulin-like growth factor-1 [IGF-1], fasting insulin, and glucose). The control group (
n
= 120) for colonoscopy was adult subjects undergoing evaluation for symptoms of irritable bowel syndrome. Clinical and biochemical parameters in acromegalic patients with colonic polyp were compared to those without a polyp.
Results:
Patients with acromegaly had significantly higher prevalence of colonic polyp as compared to control subjects (10.6% vs. 0.8%). None of the patients with polyp had skin tags. There was no significant difference between subjects with and without colonic polyp in duration of illness, basal, and glucose-suppressed GH and most recent IGF-1. Fasting blood sugar was significantly higher (
P
< 0.05) in adenoma group after adjusting for age, body mass index (BMI), and insulin levels. Patients in adenoma group showed a trend toward male gender and younger age as compared to those without adenoma.
Conclusions:
Subjects with acromegaly as compared to control have a higher prevalence of colonic polyps. There was no association of polyps seen with age, BMI, skin tags, homeostasis model assessment of insulin resistance index, duration of disease, and basal and glucose-suppressed GH and IGF-1 levels. There were no specific predictive factors detected. Screening full colonoscopy is recommended in all cases with acromegaly.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study
p. 443
Abdel Rahman El Shiekh, Hesham A Farrag, Tarek Ashour, Khalid Zaki Alshali, Waleed AbdelFattah
DOI
:10.4103/2230-8210.183461
PMID
:27366709
Aim:
To evaluate the safety profile of insulin detemir (IDet) in people with Type 2 diabetes mellitus (T2DM) in the Gulf countries in the 32-week, noninterventional LevSafe study.
Methods:
People with T2DM whose physicians had opted to start IDet therapy were included in the study. Safety parameters, including serious adverse drug reactions (SADRs) and hypoglycemia, and changes in body weight and glycemic control were evaluated at baseline, week 16 and week 32.
Results:
A total of 686 patients were exposed to IDet therapy with a mean (±standard deviation) age, body mass index, and diabetes duration of 51.3 ± 11.0 years, 31.3 ± 5.5 kg/m
2
, and 10.2 ± 6.1 years, respectively. The mean total daily dose of IDet was 32.0 ± 32.8 U at baseline and 44.7 ± 60.7 U at week 32. No SADRs were reported during the study. Total hypoglycemia decreased from 435 events at baseline to 204 events at week 32 (mean change analyzed by Wilcoxon signed rank test: −0.34;
P
= 0.0115), and no major hypoglycemia was reported at week 32. Over the 32-week treatment period, the mean body weight decreased from 85.7 ± 15.2 kg to 85.4 ± 14.5 kg (
P
= 0.0203), glycated hemoglobin A1c from 9.9 ± 1.67% to 7.7 ± 1.36% (
P
< 0.0001), and fasting plasma glucose from 11.9 ± 3.27 mmol/L to 7.4 ± 1.85 mmol/L (
P
< 0.0001).
Conclusion:
IDet therapy was well-tolerated and was associated with a decreased number of hypoglycemic events and improved glycemic control after 32 weeks in patients with T2DM in the Gulf countries.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center
p. 451
Vincenzo De Sanctis, Heba Elsedfy, Ashraf T Soliman, Ihab Zaki Elhakim, Nada A Soliman, Rania Elalaily, Christos Kattamis
DOI
:10.4103/2230-8210.183456
PMID
:27366710
Aim:
Chronic iron overload resulting from frequent transfusions, poor compliance to efficient chelation therapy and chronic liver disease is basically responsible for the most severe complications of thalassemia major (TM). Before conventional treatment, TM was entirely childhood disease with a very short survival. Today, survival improved to 40–50 years and becomes a prevalent disease of adulthood and in the near future it will be one of senility. Furthermore, clinical phenotype of TM is changing with age and appearance of severe complications from the heart and endocrine glands that require special health care from well-informed specialists.
Objectives:
The aims of our study were to: (1) Imprint the clinical profile of long-lived TM patients; (2) evaluate retrospectively the cumulative incidence of endocrine diseases; (3) identify potential risk factors; and (4) orient the physicians in the modified clinical phenotype and the relative patients' health needs.
Design:
A retrospective cross-sectional study followed from childhood to adulthood by the same physician in a tertiary thalassemia clinic.
Participants:
Forty-three long-lived TM patients (mean age: 50.3 ± 10.8 years; range: 45.8–59.5 years; 23 females) were studied.
Patients and Methods:
An extensive medical history, with detailed clinical and laboratory data, endocrine complications, and current treatments, was obtained.
Results:
The data indicate that 88.4% of adult TM patients suffered from at least one endocrine complication. The majority of patients developed endocrine complications in the second decade of life when serum ferritin level was very high (12/23 TM female and 8/20 TM male patients, the serum ferritin levels at the diagnosis were above 5.000 ng/ml).
Conclusions:
These data underline that endocrine and bone complications in adult TM patients are highly prevalent and necessitate close monitoring, treatment, and follow-up. Physicians' strategies to optimize chelation therapy include identifying patients who are at risk for developing organ damage, developing chelation plans, promoting compliance, and educating patients. Several clinical aspects remain to be elucidated such as growth and impairment of glucose tolerance in relation to hepatitis C virus infection. Furthermore, affordable worldwide-established long-term treatment protocols for hypogonadism and osteoporosis are needed.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (13) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India
p. 460
Sanjay Vikrant, Anupam Parashar
DOI
:10.4103/2230-8210.183457
PMID
:27366711
Background:
Disordered mineral metabolism is common complications of chronic kidney disease (CKD). However, there are limited data on the pattern of these disturbances in Indian CKD population.
Materials and Methods:
This was a prospective observational study of CKD-mineral and bone disorder (CKD-MBD) over a period of 3 years. The biochemical markers of CKD-MBD, namely, calcium, phosphorus, alkaline phosphatase, intact parathyroid hormone (iPTH), and 25-hydoxyvitamin Vitamin D3 (25OHD), were measured in newly diagnosed CKD Stage 3–5 and prevalent CKD Stage 5D adult patients.
Results:
A total of 462 patients of CKD Stage 3–5D were studied. The frequency of various biochemical abnormalities was hypocalcemia (23.8%), hypercalcemia (5.4%), hypophosphatemia (2.8%), hyperphosphatemia (55.4%), raised alkaline phosphatase (56.9%), secondary hyperparathyroidism (82.7%), and hypoparathyroidism (1.5%). 25OHD was done in 335 (72.5%) patients and 90.4% were found to have Vitamin D deficiency. About 70.6% of the patients had iPTH levels were above kidney disease outcomes quality initiative (KDOQI) target range. Nondiabetic CKD as compared to diabetic CKD had a higher alkaline phosphatase (
P
= 0.016), a higher iPTH (
P
= 0.001) a higher proportion of patients with iPTH above KDOQI target range (
P
= 0.09), and an elevated alkaline phosphatase (
P
= 0.004). The 25OHD levels were suggestive of severe Vitamin D deficiency in 33.7%, Vitamin D deficiency in 45.4%, and Vitamin D insufficiency in 11.3% patients. There was a significant positive correlation between iPTH with alkaline phosphatase (
r
= 0.572,
P
= 0.001), creatinine (
r
= 0.424,
P
= 0.001), and phosphorus (
r
= 0.241,
P
= 0.001) and a significant negative correlation with hemoglobin (
r
= −0.325, 0.001), age (
r
= −0.169,
P
= 0.002), and 25OHD (
r
= −0.126,
P
= 0.021). On multivariate logistic regression analysis, an elevated alkaline phosphatase was a significant predictor of hyperparathyroidism (odds ratio 9.7, 95% confidence interval 4.9–19.2,
P
= 0.001).
Conclusions:
There was a high prevalence of CKD-MBD in Indian CKD patients. CKD-MBD is more common and more severe and has an early onset as compared to the western populations.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Prevalence of anxiety and depressive symptoms among patients with hypothyroidism
p. 468
Manish Bathla, Manpreet Singh, Pankaj Relan
DOI
:10.4103/2230-8210.183476
PMID
:27366712
Context:
The association between depression and thyroid function is well known. Both conditions express many similar symptoms, thus making the diagnosis and treatment difficult.
Aims:
To find the prevalence of anxiety and depressive symptoms among patients with hypothyroid.
Settings and Design:
Cross-sectional study.
Materials and Methodology:
A total of 100 patients diagnosed as hypothyroidism were evaluated using Hamilton depression rating scale (HDRS) and Hamilton scale for anxiety (HAM-A).
Statistical Analysis Used:
The data were analyzed using the SPSS for Windows version 17.0 software. The quantitative data were expressed in number and percentage. The results obtained were compared using the Chi-square test.
Results:
Females constituted 70% of the sample. A total of 60% reported some degree of depression based on HDRS (males – 56.63% and females – 64.29%) whereas about 63% out of the total patients screened showed some degree of anxiety (males –56.66% and females – 65.72%) based on HAM-A. The most common depressive symptom among the males was depressed mood (73.33%) and among females was gastrointestinal somatic symptoms (68.54%). The most common anxiety symptom among the males was depressed mood (70.0%) and among females was anxious mood (92.85%).
Conclusions:
Psychiatric symptoms/disorders are common in patients with thyroid dysfunction.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (8) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Emphysematous pyelonephritis: A 10-year experience with 26 cases
p. 475
Raiz Ahmad Misgar, Idrees Mubarik, Arshad Iqbal Wani, Mir Iftikhar Bashir, Mahroosa Ramzan, Bashir Ahmad Laway
DOI
:10.4103/2230-8210.183475
PMID
:27366713
Background:
Emphysematous pyelonephritis (EPN) is a necrotizing infection which results in gas within the renal parenchyma, collecting system, or perinephric tissue. A majority of cases occur in patients with diabetes mellitus (DM). In EPN, early aggressive medical treatment may avoid nephrectomy.
Aims:
The aim of this study was to analyze the characteristics of patients with EPN with respect to patient demographics, clinical presentation, diagnostic investigations, microbiological findings, treatment modality and outcome, and the influence of prognostic factors on the outcome.
Materials and Methods:
We reviewed the hospital records of 26 patients with EPN for clinical, laboratory, radiological, and microbiological findings, treatments given, and outcome. The severity of EPN was graded as per the Huang classification. We applied the reported prognostic factors to our patients to find out whether these factors correlated with failure of conservative treatment.
Results:
All the study subjects had DM and all but two of them were females. The majority of our patients (61.5%) had extensive EPN (class 3 or 4) and majority (76.9%) had two or more bad prognostic factors.
Escherichia coli
was the most common causative organism involved in 50% of our cases. Twenty-three (88.5%) of our patients responded to conservative treatment, two required nephrectomy, and one expired on conservative treatment.
Conclusions:
In this series of patients with EPN, all had DM, nearly all were women, and
E. coli
was the most frequently isolated pathogen. Nearly a third of our patients had bilateral disease. Despite the presence of two or more bad prognostic factors and extensive EPN (class 3 or 4) in a majority of our patients, conservative treatment afforded a striking success rate of 88.5%. We recommend early aggressive medical treatment and suggest that nephrectomy should be considered only if patients deteriorate or do not improve on conservative treatment.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (8) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Glycemic control and pregnancy outcomes in patients with diabetes in pregnancy: A retrospective study
p. 481
Badurudeen Mahmood Buhary, Ohoud Almohareb, Naji Aljohani, Saad H Alzahrani, Samer Elkaissi, Suphia Sherbeeni, Abdulrahman Almaghamsi, Mussa Almalki
DOI
:10.4103/2230-8210.183478
PMID
:27366714
Context:
Diabetes in pregnancy (DIP) is either pregestational or gestational.
Aims:
To determine the relationship between glycemic control and pregnancy outcomes in a cohort of DIP patients.
Settings and Design:
In this 12-month retrospective study, a total of 325 Saudi women with DIP who attended the outpatient clinics at a tertiary center Riyadh, Saudi Arabia, were included.
Subjects and Methods:
The patients were divided into two groups, those with glycated hemoglobin (HbA1c) ≤6.5% (48 mmol/mol) and those with glycated hemoglobin (HbA1c) above 6.5%. The two groups were compared for differences in maternal and fetal outcomes.
Statistical Analysis Used:
Independent Student's
t
-test and analysis of variance were performed for comparison of continuous variables and Chi-square test for frequencies. Odds ratio and 95% confidence intervals were calculated using logistic regression.
Results:
Patients with higher HbA1c were older (
P
= 0.0077), had significantly higher blood pressure, proteinuria (
P
< 0.0001), and were multiparous (
P
= 0.0269). They had significantly shorter gestational periods (
P
= 0.0002), more preterm labor (
P
< 0.0001), more perineal tears (
P
= 0.0406), more miscarriages (
P
< 0.0001), and more operative deliveries (
P
< 0.0001). Their babies were significantly of greater weight, had more Neonatal Intensive Care Unit (NICU) admissions, hypoglycemia, and macrosomia.
Conclusions:
Poor glycemic control during pregnancy is associated with adverse maternal and fetal outcomes (shortened gestational period, greater risk of miscarriage, increased likelihood of operative delivery, hypoglycemia, macrosomia, and increased NICU admission). Especially at risk are those with preexisting diabetes, who would benefit from earlier diabetes consultation and tighter glycemic control before conception.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (7) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Comparison of maternal and fetal outcomes among Asian Indian pregnant women with or without gestational diabetes mellitus: A situational analysis study (WINGS-3)
p. 491
Manni Mohanraj Mahalakshmi, Balaji Bhavadharini, Kumar Maheswari, Gunasekaran Kalaiyarasi, Ranjit Mohan Anjana, Unnikrishnan Ranjit, Viswanathan Mohan, Kurian Joseph, Kurian Rekha, Sivagnanam Nallaperumal, Belma Malanda, Arivudainambi Kayal, Anne Belton, Ram Uma
DOI
:10.4103/2230-8210.183469
PMID
:27366715
Aim:
To compare the existing maternal and fetal outcomes in Asian Indian women with or without gestational diabetes mellitus (GDM) before the development of the Women in India with GDM Strategy (WINGS) GDM model of care (MOC).
Materials and Methods:
Records of pregnant women were extracted retrospectively from three maternity centers in Chennai. GDM was diagnosed using the International Association for Pregnancy Study Groups criteria or the Carpenter and Coustan criteria. Demographic details, obstetric history, antenatal follow-up, treatment for GDM, and outcomes of delivery were collected from the electronic medical records.
Results:
Of the 3642 records analyzed, 799 (21.9%) had GDM, of whom 456 (57.1%) were treated with insulin and medical nutrition therapy (MNT), 339 (42.4%) with MNT alone, and 4 (0.5%) with metformin. Women with GDM were older than those without (28.5 ± 4.5 vs. 27.1 ± 4.5 years;
P
< 0.001) and had higher mean body mass index at first booking (26.4 ± 5.2 kg/m
2
vs. 25.2 ± 5.1 kg/m
2
;
P
< 0.001). Rates of cesarean section (26.2% vs. 18.7%;
P
< 0.001), preeclampsia (1.8% vs. 0.8%;
P
= 0.04), and macrosomia (13.9% vs. 10.8%;
P
= 0.02) were significantly higher among women with GDM. In women with GDM treated with insulin and MNT, emergency cesarean section (16.2% vs. 36.6%;
P
< 0.0001), preeclampsia (0.7% vs. 3.2%;
P
= 0.015), and macrosomia (9.9% vs. 18.6%;
P
= 0.0006) were significantly lesser compared to those treated with MNT alone.
Conclusion:
Pregnancy outcomes were in general worse in GDM women. Treatment with insulin was associated with a significantly lower risk of complications. However, in countries with limited access to insulin and other medicines may lead to poor follow-up and management of GDM. Data from this retrospective study will form the basis for the development of the WINGS GDM MOC, which will address these gaps in GDM care in low-resource settings.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Premature birth and insulin resistance in infancy: A prospective cohort study
p. 497
Vikas Payal, Rakesh Jora, Pramod Sharma, Pradeep Kumar Gupta, Mukesh Gupta
DOI
:10.4103/2230-8210.183470
PMID
:27366716
Objective:
This study was done to determine the role of prematurity and other variables to predict insulin sensitivity in infancy.
Subjects and Methods:
In this prospective study, 36 preterm appropriate for gestational age (AGA), 11 preterm small for gestational age (SGA), and 17 term SGA included as study cohort and 36 term AGA as control cohort. Detailed anthropometry assessment was performed at birth, 3, 6, and 9 months and at 9 months, fasting plasma glucose and serum insulin was done. Insulin resistance was determined by using homeostasis model assessment version 2.
Results:
It is found that preterm AGA (mean difference 0.617, 95% confidence interval [CI]; 0.43–0.80,
P
= 0.0001), preterm SGA (mean difference 0.764, 95% CI; 0.44–1.09,
P
= 0.0001), and term AGA (mean difference 0.725, 95% CI; 0.49–0.96,
P
= 0.0001) group had significantly higher insulin resistance than control. There was no significant difference in between preterm SGA and preterm AGA (mean difference 0.147 95% CI; −0.13–0.42,
P
= 0.927). In multiple regression models, SGA status (β =0.505) was more significant predictor of insulin resistance index than gestational age (β = −0.481), weight-for-length (β =0.315), and ponderal index (β = −0.194).
Conclusion:
Preterm birth is a risk factor for the future development of insulin resistance which may develop as early as infancy.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (3) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Impact of insulin pump on quality of life of diabetic patients
p. 506
Haider Ghazanfar, Syed Wajih Rizvi, Aliya Khurram, Fizza Orooj, Iman Qaiser
DOI
:10.4103/2230-8210.183472
PMID
:27366717
Aim:
Diabetes is an emerging health problem, both in developing and developed countries and has an enormous economic and social impact. The objective of our study was to find the impact of insulin pump on the quality of life of patients with type 2 diabetes (T2D) and compare it to the quality of life of patients with T2D using an insulin pen.
Subjects and Methods:
This is a case–control study which was conducted among patients with T2D presenting between November 2014 and November 2015. A total of 83 patients with T2D, using insulin pump were enrolled in the study as cases and 322 patients with T2D not using insulin pump but using insulin pens were enrolled as controls. Short form-36 quality of life questionnaire was used for data collection.
Results:
Mean age of patients using insulin pump was 52.49 ± 9.28 while the mean age of patients not using insulin pump was 54.72 ± 16.87. Mean score of all domains in the questionnaire was found to be higher in patients using insulin pump as compared to patients not using insulin pumps (
P
< 0.05). In 81.1% of the patients, the insulin pump decreased the frequency of hypoglycemic episodes.
Conclusion:
Insulin pump has significantly improved the quality of life of patients in terms of better self-esteem, decreased stress, and better mood. It has resulted in improved physical health, meal time flexibility, and ease of travel. It allows patient to have more active participation in social and recreational activities improving their personal and family life.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (7) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Is intraoperative parathyroid hormone monitoring necessary in symptomatic primary hyperparathyroidism with concordant imaging?
p. 512
C Gopalakrishnan Nair, Misha J.C. Babu, Pradeep Jacob, Riju Menon, Jimmy Mathew
DOI
:10.4103/2230-8210.183451
PMID
:27366718
Introduction:
Symptomatic primary hyperparathyroidism (PHPT) is still seen frequently in referral centers all over India. These patients require parathyroidectomy and this study aimed to assess the roll of intraoperative parathyroid hormone (PTH) assay when concordant results of two localization studies were available.
Study Design:
We analyzed the case records of patients who underwent parathyroidectomy for PHPT from January 2005 to June 2015.
Results:
Of 143 patients included in the study, technetium 99m methoxyisobutylisonitrate dual phase scintigraphy showed true positive images in 93.7% and high definition ultrasonography in 84.6% of patients. Concordance in localization studies was observed in 121 (84.6%) patients, successful parathyroidectomy was done in 117 (96.7%) patients with concordant localization studies. Intraoperative PTH monitoring showed 97.84% sensitivity and 75% specificity and predicted failure in 2 patients with concordant imaging. However, re-exploration was not successful in these patients.
Conclusion:
When concordant result is available between parathyroid scintigraphy and anatomical imaging surgical cure rate is high in trained hands. Re-exploration is unlikely to be successful since these patients require higher imaging.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
A community-based case–control study to investigate the role of iron deficiency in the persistence of goiter
p. 517
Rambha Pathak, Chintu Chaudhary, Rashmi Agarwalla, Zakirhusain Shaikh, R.K.D. Goel, Bilkish Patvegar
DOI
:10.4103/2230-8210.183466
PMID
:27366719
Objectives:
To find out the magnitude of iron deficiency anemia in the age group of 6–12 years and investigate the role of iron deficiency as a possible contributor to endemic goiter in school children in Ambala.
Materials and Methods:
The present study was conducted as a subset of a cross-sectional study among 2700 children from 6 to 12 years of age to find out the prevalence of goiter. All the subjects who were found to be suffering from goiter in the cross-sectional study were enrolled in the case–control study as cases and were compared with age- and sex-matched controls (children without goiter) from the same cohort. The study was conducted from February 2011 to January 2012.
Results:
Out of total, goiter was observed in 12.6% of the subjects. Urinary iodine excretion was found to be <100 μg/L in 57 (10.5%) children. Mean hemoglobin (Hb) level of the study population was 11.9 g/dL. It was noted that 71% of the goitrous children had anemia (Hb <12 g/dL) as compared to 63.7% of the control group. Serum ferritin (SF) was <15 ng/mL in 70% of the children. The mean ± standard deviation of SF in the goitrous and nongoitrous children was 19.65 ± 32.51 μg/L and 27.55 ± 21.07 μg/L, respectively (
P
= 0.012).
Conclusion:
The findings in the study suggest that iron deficiency anemia in children is contributing toward the persistence of goiter in the postiodization phase.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
Gut Microbiota in Type 2 Diabetes Individuals and Correlation with Monocyte Chemoattractant Protein1 and Interferon Gamma from Patients Attending a Tertiary Care Centre in Chennai, India
p. 523
Premalatha Pushpanathan, Padma Srikanth, Krishna G Seshadri, Sribal Selvarajan, Ravi Shankar Pitani, Thomas David Kumar, R Janarthanan
DOI
:10.4103/2230-8210.183474
PMID
:27366720
Background:
Type 2 diabetes mellitus (T2DM) and obesity are associated with changes in gut microbiota and characterized by chronic low-grade inflammation. Monocyte chemoattractant protein-1 (MCP-1) and interferon gamma (IFNγ) are proinflammatory cytokines which play an important role in the development of T2DM. We undertook this study to analyze the gut microbiota of T2DM and nondiabetic subjects and to determine the profile of MCP 1 and IFNγ in the same subjects attending a tertiary care center in Chennai, Tamil Nadu, India.
Methods:
The study included 30 subjects with clinical details. Stool and blood samples were collected from all the subjects. DNA was extracted from fecal samples and polymerase chain reaction was done using fusion primers. Metagenomic analysis was performed using ion torrent sequencing. The reads obtained were in FASTA format and reported as operational taxonomic units. Human MCP 1 and IFNγ enzyme linked immunosorbent assay (ELISA) were performed for 23 serum samples.
Results:
The study consisted of 30 subjects; 17 were T2DM and 13 were nondiabetics. The gut microbiota among T2DM consisted predominantly of Gram negative bacteria;
Escherichia
and
Prevotella
, when compared with the nondiabetic group with predominantly Gram positive organisms suchas
Faecalibacterium
,
Eubacterium
, and
Bifidobacterium
. The mean MCP-1 values in the diabetic group were 232.8 pg/ml and in the nondiabetic group 170.84 pg/ml. IFNγ (mean 385.5 pg/ml) was raised in glycated hemoglobin (HbA1c) group of 6.5–7.5% which was statistically significant. Association of
Escherichia
with T2DM and association of
Bifidobacteria
in the nondiabetics were also statistically significant.
Conclusion:
Escherichia
counts were elevated in T2DM with HbA1c of 6.5–8.5% which was statistically significant suggesting that lipopolysaccharides present in the cell wall of Gram-negative bacteria may be responsible for low-grade inflammation as evidenced by elevated MCP-1 and IFNγ levels in T2DM with the same HbA1c levels.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (11) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Growth status of small for gestational age Indian children from two socioeconomic strata
p. 531
Vaman V Khadilkar, Rubina M Mandlik, Sonal A Palande, Deepa S Pandit, Meghna Chawla, Ruchi Nadar, Shashi A Chiplonkar, Sandeep S Kadam, Anuradha A Khadilkar
DOI
:10.4103/2230-8210.183473
PMID
:27366721
Aims:
To assess growth and factors associated with growth in children born small for gestational age (SGA) from two socioeconomic strata in comparison to age- and sex-matched healthy controls.
Methods:
Retrospective study conducted at two hospitals in Pune, 0.5–5 years, 618 children: 189-SGA from upper socioeconomic strata (USS), 217-SGA from lower socioeconomic strata (LSS), and 212 appropriate for gestational age healthy controls were randomly selected. Birth and maternal history, socioeconomic status, length/height, and weight of children were recorded. Anthropometric data were converted to Z scores (height for age Z-score [HAZ], weight for age Z-score [WAZ]) using WHO AnthroPlus software.
Results:
The HAZ and WAZ of the SGA group were significantly lower as compared to the controls and that of the LSS SGAs were lower than USS SGAs (
P
< 0.05). Thirty two percent children were stunted (HAZ <−2.0) in USS and 49% in LSS (
P
< 0.05). Twenty nine percent children in the USS SGA group were stunted at 2 years and 17% at 5 years. In the LSS SGA group, 54% children were stunted at 2 years and 46% at 5 years. Generalized linear model revealed normal vaginal delivery (β = 0.625) and mother's age (β =0.072) were positively associated and high SES (β = −0.830), absence of major illness (β = −1.01), higher birth weight (β = −1.34) were negatively associated for risk of stunting (
P
< 0.05).
Conclusion:
Children born SGA showed poor growth as compared to controls. Special attention to growth is necessary in children from LSS, very low birth weight babies, and those with major illnesses during early years of life.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Gender identity and gender of rearing in 46 XY disorders of sexual development
p. 536
Arushi Gangaher, Vasundhera Chauhan, Viveka P Jyotsna, Manju Mehta
DOI
:10.4103/2230-8210.183471
PMID
:27366722
Background:
Disorders of sexual development (DSD) may pose a challenge to live as a fully-functioning male or female. In this study, we prospectively assessed eleven 46 XY DSD patients who were being treated at our center over the last 8 months for gender dysphoria.
Materials and Methods:
To determine gender dysphoria, age-appropriate gender identity (GI) questionnaires were used. For patients, 12 years and below, parent report GI questionnaire for children was used and for those above 12 years of age, GI/gender dysphoria questionnaire for adolescents and adults was administered.
Results:
Of 11 patients with 46 XY DSD, three were diagnosed with 5 alpha reductase deficiency (5aRD), two with partial gonadal dysgenesis, three with partial androgen insensitivity syndrome, one each with ovotesticular, complete gonadal dysgenesis, and complete androgen insensitivity. Gender assigned at birth was female in eight and male in three patients. Among the eight reared as female, gender had been reassigned as male in three patients well before the present study was conducted. None of the eleven patients had gender dysphoria at the time of this study.
Conclusion:
Early gender of rearing was seen to be a critical indicator of present GI in our patients except in cases of 5aRD.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (4) ]
[PubMed]
[Sword Plugin for Repository]
Beta
REVIEW ARTICLES
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
p. 542
Sanjay Kalra, Zafar A Latif, Abdurrahman Comlekci, Guillermo Gonzalez Galvez, Rached Malik, Md Faruque Pathan, Ajay Kumar
DOI
:10.4103/2230-8210.182980
PMID
:27366723
Insulin degludec/insulin aspart (IDegAsp) is a modern coformulation of ultra-long-acting basal insulin degludec, with rapid-acting insulin aspart. IDegAsp provides effective, safe, well-tolerated glycemic control, with a low risk of hypoglycemia while allowing flexibility in meal patterns and timing of administration. This consensus statement describes a pragmatic framework to identify patients who may benefit from IDegAsp therapy. It highlights the utility of IDegAsp in type 2 diabetic patients who are insulin-naive, suboptimally controlled on basal or premixed insulin, or dissatisfied with basal–bolus regimens. It also describes potential IDegAsp usage in type 1 diabetic patients.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
p. 546
Aastha Chawla, Rajeev Chawla, Shalini Jaggi
DOI
:10.4103/2230-8210.183480
PMID
:27366724
Diabetes and related complications are associated with long-term damage and failure of various organ systems. The line of demarcation between the pathogenic mechanisms of microvascular and macrovascular complications of diabetes and differing responses to therapeutic interventions is blurred. Diabetes induces changes in the microvasculature, causing extracellular matrix protein synthesis, and capillary basement membrane thickening which are the pathognomic features of diabetic microangiopathy. These changes in conjunction with advanced glycation end products, oxidative stress, low grade inflammation, and neovascularization of vasa vasorum can lead to macrovascular complications. Hyperglycemia is the principal cause of microvasculopathy but also appears to play an important role in causation of macrovasculopathy. There is thought to be an intersection between micro and macro vascular complications, but the two disorders seem to be strongly interconnected, with micro vascular diseases promoting atherosclerosis through processes such as hypoxia and changes in vasa vasorum. It is thus imperative to understand whether microvascular complications distinctly precede macrovascular complications or do both of them progress simultaneously as a continuum. This will allow re-focusing on the clinical issues with a unifying perspective which can improve type 2 diabetes mellitus outcomes.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (223) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Hypothyroidism and obesity: An intriguing link
p. 554
Debmalya Sanyal, Moutusi Raychaudhuri
DOI
:10.4103/2230-8210.183454
PMID
:27366725
According to common perception, hypothyroidism is held responsible for obesity. However, linking them causally is controversial. Overt hypothyroidism is associated with modest weight gain, but there is a lack of clarity regarding subclinical hypothyroidism. Novel view indicates that changes in thyroid-stimulating hormone (TSH) could well be secondary to obesity. The increasing prevalence of obesity further confounds definition of normal TSH range in population studies. Thyroid autoantibody status may help in establishing the diagnosis of subclinical hypothyroidism in obesity. High leptin levels may play a role in the hyperthyrotropinemia of obesity and also increase susceptibility to thyroid autoimmunity and subsequent hypothyroidism. There is at most a modest effect of L-T4 treatment in overt hypothyroidism in inducing weight loss; benefit in subclinical hypothyroidism is not established with no data supporting thyroid hormone use in euthyroid obese patients.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (40) ]
[PubMed]
[Sword Plugin for Repository]
Beta
ENDOCRINOLOGY AND THE ARTS
The neuroendocrinology of love
p. 558
Krishna G Seshadri
DOI
:10.4103/2230-8210.183479
PMID
:27366726
Romantic love could be considered as a collection of activities associated with the acquisition and retention of emotions needed to survive and reproduce. These emotions change the individual's behavioural strategies in a way that will increase the likelihood of achieving these goals. Love may be defined as an emergent property of an ancient cocktail of neuropeptides and neurotransmitters. It appears that lust, attachment and attraction appear to be distinct but intertwined processes in the brain each mediated by its own neurotransmitters and circuits. These circuits feed on and reinforce each other. Sexual craving is mediated by testosterone and oestrogen and has the amygdala as an important centre. Attraction is mediated by hormones of stress and reward including dopamine, norepinephrine cortisol and the serotinergic system and has the nucleus accumbens the ventral tegmental area as key mediators.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (3) ]
[PubMed]
[Sword Plugin for Repository]
Beta
BRIEF COMMUNICATIONS
Insulin degludec and insulin degludec/insulin aspart in Ramadan: A single center experience
p. 564
Sanjay Kalra
DOI
:10.4103/2230-8210.180644
PMID
:27366727
This study aimed to document the utility and safety of insulin degludec (IDeg) and insulin degludec aspart (IDegAsp) in persons with type 2 diabetes, observing the Ramadan fast. An observational study was conducted at a single center, in the real world setting, on six persons who either switched to IDeg or IDegAsp a month before Ramadan or changed time of administration of IDegAsp at the onset of Ramadan, to keep the fast in a safe manner. Subjects were kept under regular monitoring and surveillance before, during, and after Ramadan, and counseled in an opposite manner. Four persons, who shifted from premixed insulin to IDegAsp, experienced a 12–18% dose reduction after 14 days. At the onset of Ramadan, the Suhur dose was reduced by 30%, and this remained unchanged during the fasting month. The Iftar dose had to be increased by 4 units. One person who shifted from neutral protamine hagedorn to IDeg demonstrated a 25% dose reduction at 20 days, without any further change in insulin requirement during Ramadan. One person who changed time of injection of IDegAsp from morning to night reported no change in dosage. No episode of major hypoglycemia was reported. IDeg and IDegAsp are effective, safe, and well-tolerated means of achieving glycemic control in persons with type 2 diabetes who wish to fast.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (6) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Alternate-day dosing of linagliptin in type 2 diabetes patients controlled on once daily dose: A case series
p. 568
Manash P Baruah, Sonali B Bhuyan, Jumi Deka, Jatin Bora, Smritisikha Bora, Murchana Barkakati
DOI
:10.4103/2230-8210.183468
PMID
:27366728
Linagliptin, a dipeptidyl peptidase 4 (DPP 4) inhibitor with a long terminal half life, significantly inhibits the DPP 4 enzyme at a steady state up to 48 h after the last dose. The present case series examined the hypothesis that linagliptin retains its efficacy during alternate day dosing in type 2 diabetes patients when switched over from once daily (OD) dosing. Eight type 2 diabetes patients maintaining stable glycosylated hemoglobin (HbA1c) with acceptable fasting plasma glucose and postprandial glucose levels and receiving linagliptin 5 mg OD for at least 6 weeks, with a stable dose of concomitant antidiabetic medications were given linagliptin 5 mg every alternate day. The median HbA1c while on the OD regimen was 6.1% (43 mmol/mol) (range: 5.8–6.9% [40–52 mmol/mol]) and median duration of diabetes was 7 years (range: 0.75–16 years). After a median follow-up period of 21weeks,the glycemic control was maintained in all patients similar to their baseline values (median HbA1c: 6.0% [42 mmol/mol], range: 5.1–7.1% [32–54 mmol/mol]). The body weight, fasting, and random glucose levels at baseline were also well maintained at the end of treatment. Optimal glycemic status maintained in our study population favors our hypothesis that linagliptin used alternate daily after switching from initial OD dose of the drug in patients on a stable background antidiabetic medications retains its efficacy. Paradoxically, alternate day dosing may affect compliance if the patient forgets when they took the last dose. Further studies including larger cohorts are needed to validate this finding and identify patients who can benefit from the alternate day regimen.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
LETTERS TO THE EDITOR
Coexisting Turner's syndrome, Hashimoto's thyroiditis, and growth hormone deficiency
p. 573
Ibtissem Oueslati, Karima Khiari, Insaf Hadj Ali, Néjib Ben Abdallah
DOI
:10.4103/2230-8210.183458
PMID
:27366729
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
Biosimilar insulins: An unavoidable option in South-East Asia
p. 574
Prashant Ulhas Kaduskar
DOI
:10.4103/2230-8210.183462
PMID
:27366730
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Ketoacidosis in diabetic subjects treated with inhibitors of Na
+
-glucose co-transporters type-2: New mechanisms?
p. 576
Paolo Tessari
DOI
:10.4103/2230-8210.183465
PMID
:27366731
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
Reply to the editorial – “Only generics (drugs/names): Is India ready?”
p. 577
Rakesh Kumar Sahay, Jayaprakashsai Jana
DOI
:10.4103/2230-8210.183463
PMID
:27366732
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
Mighty journals, mega trials, and modest points
p. 578
K.V.S. Hari Kumar, KD Modi, Sanjay Kalra
DOI
:10.4103/2230-8210.183464
PMID
:27366733
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Autoimmune polyglandular syndrome type II: Schimidt's syndrome, a unifying diagnosis in a case presenting with an uncommon combination of multiple endocrine disorders
p. 579
Amitabh Sagar, Arun Valson, Manish Bhartiya
DOI
:10.4103/2230-8210.183477
PMID
:27366734
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
Hyperparathyroidism in dentistry: Issues and challenges!!
p. 581
Yogita Khalekar, Amit Zope, Ujwala Brahmankar, Lalit Chaudhari
DOI
:10.4103/2230-8210.183452
PMID
:27366735
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Feedback
Subscribe
Next Issue
Previous Issue
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
© Indian Journal of Endocrinology and Metabolism | Published by Wolters Kluwer -
Medknow
Online since 10 December, 2010